Drug
Nicotine Polacrilex
Nicotine Polacrilex: highest development phase Approved, developed by Perrigo. 1 trial record tracked on RxWires.
- Highest phase
- Approved
- Developer
- Perrigo
Trials
| Drug | Phase | Indication |
|---|---|---|
| KIRKLAND SIGNATURE QUIT 4 | Approved |
Latest
Follow Nicotine Polacrilex on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.